MENU
RVNC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Revance Therapeutics (RVNC) Ownership - Who owns Revance Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
320.48M
P/E Ratio
N/A
Total Cash
184.08M
Projected Growth
N/A
Total Debt
483.45M
Revenue
256.95M
Risk (Beta)
1.06
Dividend Yield
N/A
Total Cash/Share
1.76
Total Debt/Equity
N/A
Revenue/Share
2.66 USD as % of share price
Fundamentals
RVNC
Capitalization
320M
P/E Ratio
N/A
Risk (Beta)
1.06
Dividend Yield
N/A
Total Cash
184M
Total Cash/Share
1.76
Total Debt
483M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.66%
Revenue
257M
ROE
N/A
Book Value
-163.03M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
105K
Current Ratio
4.12
Current Revenue Per Employee
100299.84
Dividends Per Share - Security
N/A
EBITDA
-269.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
70.55
Revenue To Assets
-37.11
Shares Held By Institutions
384M
Shares Outstanding - Current
104M
Total Liabilities
625M
Total Volume MTD
N/A
Value
-1
Gain YTD
-65.074
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com